Regulatory Exclusivity: NEW DOSING SCHEDULE
✉ Email this page to a colleague
Drugs with New Dosing Schedule Regulatory Exclusivity
Click here to exclude patents covering these drugs from this list
| Applicant | Tradename | Generic Name | NDA | Approval Date | Type | Patent No. | Patent Expiration | Exclusivity Expiration | Patented / Exclusive Use |
|---|---|---|---|---|---|---|---|---|---|
| Puma Biotech | NERLYNX | neratinib maleate | 208051 | Jul 17, 2017 | RX | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | NEW DOSING REGIMEN FOR THE PREVENTION AND MANAGEMENT OF NERATINIB‐ASSOCIATED DIARRHEA |
| Puma Biotech | NERLYNX | neratinib maleate | 208051 | Jul 17, 2017 | RX | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | NEW DOSING REGIMEN FOR THE PREVENTION AND MANAGEMENT OF NERATINIB‐ASSOCIATED DIARRHEA |
| Puma Biotech | NERLYNX | neratinib maleate | 208051 | Jul 17, 2017 | RX | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | NEW DOSING REGIMEN FOR THE PREVENTION AND MANAGEMENT OF NERATINIB‐ASSOCIATED DIARRHEA |
| Puma Biotech | NERLYNX | neratinib maleate | 208051 | Jul 17, 2017 | RX | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | NEW DOSING REGIMEN FOR THE PREVENTION AND MANAGEMENT OF NERATINIB‐ASSOCIATED DIARRHEA |
| Puma Biotech | NERLYNX | neratinib maleate | 208051 | Jul 17, 2017 | RX | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | NEW DOSING REGIMEN FOR THE PREVENTION AND MANAGEMENT OF NERATINIB‐ASSOCIATED DIARRHEA |
| >Applicant | >Tradename | >Generic Name | >NDA | >Approval Date | >Type | >Patent No. | >Patent Expiration | >Exclusivity Expiration | >Patented / Exclusive Use |
